The hCG Total Quantitative Test measures human chorionic gonadotropin levels in blood to confirm pregnancy and monitor its progression. It provides exact hCG values, helping detect ectopic pregnancy, miscarriage risk, and abnormal growths like trophoblastic disease. Doctors also use it to track fertility treatments and evaluate certain cancers. This test offers precise insight into pregnancy health, reproductive function, and overall hormone balance.

The hCG Total Qualitative Test detects the presence of human chorionic gonadotropin in blood to confirm pregnancy. Unlike the quantitative test, it provides a simple positive or negative result rather than exact levels. Doctors use this test to confirm suspected pregnancy, evaluate early symptoms, or screen before medical procedures.

The hCG Test with Gestational Table is a blood test that tracks human chorionic gonadotropin to confirm pregnancy and assess fetal growth. Comparing results with gestational reference ranges helps evaluate maternal health, monitor early development, and identify potential complications such as ectopic pregnancy, miscarriage, or abnormal hormone trends linked to reproductive health.

The hCG Qualitative Urine Test detects human chorionic gonadotropin in urine to confirm pregnancy. It provides a simple positive or negative result, making it similar to an at-home pregnancy test but performed in a clinical setting for greater accuracy. Doctors order this test to evaluate missed periods, early pregnancy symptoms, or before medical procedures.

The Pregnancy Blood Test is a qualitative test that detects human chorionic gonadotropin (hCG) in blood and reports results as Positive or Negative. A positive result confirms pregnancy, while a negative means no hCG detected. More sensitive than urine tests, it can confirm pregnancy in early stages. Doctors use this test to verify pregnancy, evaluate symptoms, or provide reliable confirmation for women seeking accurate reproductive health answers.

The Pregnancy Urine Test detects human chorionic gonadotropin (hCG), a hormone produced shortly after implantation, to confirm pregnancy. It provides quick, reliable results from a urine sample and is often used to verify early pregnancy when a menstrual period is missed. Doctors may order this test to confirm results before beginning prenatal care. It is a simple, accurate, and widely used screening tool for pregnancy detection.

The Pregnancy TSH Test measures thyroid-stimulating hormone levels to evaluate thyroid function during pregnancy. Abnormal TSH may indicate hypothyroidism or hyperthyroidism, conditions that can affect maternal health and fetal development. Doctors use this blood test to detect thyroid imbalances early, monitor treatment, and ensure proper hormone regulation, supporting a healthy pregnancy and reducing risks of complications for both mother and baby.

The Estriol (E3) Test checks blood levels of estriol, an estrogen hormone important in pregnancy. It is commonly included in the second-trimester triple or quad screen to detect chromosomal disorders such as Down syndrome and assess placental function. Estriol testing helps monitor fetal growth and maternal hormone health. Low or abnormal levels may signal pregnancy complications, guiding further testing and prenatal care decisions.

The Progesterone Test measures progesterone levels in blood to evaluate ovulation, fertility, and menstrual health. It helps confirm whether ovulation has occurred, assess causes of infertility, and monitor hormone therapy or high-risk pregnancies. Doctors also use it to investigate abnormal bleeding, detect ovarian or adrenal disorders, and evaluate miscarriage risk. This test provides key insight into reproductive, hormonal, and overall endocrine health.

The Maternal AFP Test evaluates alpha-fetoprotein levels during pregnancy to assess fetal development and identify possible abnormalities. Variations in AFP may signal neural tube defects, abdominal wall issues, or genetic conditions such as trisomy 21. As part of prenatal screening, this test provides insight into maternal health and supports early evaluation of fetal growth and pregnancy outcomes.

The Progesterone Ultrasensitive Test measures very low progesterone levels in blood with high accuracy to evaluate reproductive and endocrine health. Doctors use it to assess menstrual cycle function, confirm ovulation, investigate infertility, and monitor hormone therapy. It is also useful in pregnancy evaluation and detecting hormonal disorders. Results provide precise insight into progesterone balance, fertility, and overall reproductive health.

 The CA-3 Cancer Screening - Women panel is an extensive diagnostic tool designed for an in-depth analysis of various cancer-related markers, specifically tailored for women. This advanced screening panel integrates additional markers to enhance the detection and monitoring capabilities for a broad spectrum of cancers. It is instrumental in providing a comprehensive overview of a woman's cancer risk profile, facilitating early intervention, and guiding effective treatment strategies.

 The CA-4 Cancer Screening - Women panel is the most comprehensive diagnostic tool available for assessing cancer risk and monitoring the health of women potentially at high risk for various cancers. It encompasses an extensive range of biomarkers, each specifically chosen to detect early signs of cancer and monitor treatment progress or recurrence. This panel is essential for women with a significant family history of cancer, known genetic predispositions, or those who have had previous cancer diagnoses and need close surveillance.